OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

Core Insights - OptimizeRx Corp. plans to appoint a new independent director to its Board of Directors in the second half of 2025 as part of its strategy to refresh and expand the Board [1][2] - The current Board consists of five directors, with three new members added since 2020, indicating a proactive approach to governance and strategic alignment [2] - The company is focused on executing its growth strategy under the leadership of new CEO Steve Silvestro, aiming to enhance brand visibility and drive profitable revenue growth in the healthcare technology sector [3] Company Overview - OptimizeRx is a leading provider of healthcare technology solutions that facilitate connections between life sciences companies, healthcare professionals, and patients [4] - The company utilizes innovative AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to enhance engagement and improve patient outcomes [4][5] - OptimizeRx is committed to privacy-safe, patient-centric technology, partnering with top pharmaceutical and life sciences companies to transform the healthcare landscape [5]